M

Meneldor

6 employees

Meneldor is a biopharmaceutical investment company .

Investor insights

Sectors invested in

Biotechnology5
Health Care3
Pharmaceutical3
Viral infection2
MEK inhibitors2
Health Diagnostics2
Antivirals2
Respiratory infection2
Science2
Innovation2
Biopharma2
Influenza2
Therapeutics2
QC reagents1
Drug development1
ADCs / AOCs1
Biomarker discovery1
Assay Development1
Custom reagents1
Environmental testing1

Funding rounds participated in

$6.6M sweet spot round size

Most of their 5 investments are in rounds between $2.2M and $10M

Basic info

Industry

venture capital and private equity principals

Sectors

Strategic Program Development
Project Management
Biopharma
Management of technology and investments companies
Biopharmaceutical
Investment

Date founded

2016

Investments made

T

Tagworks Pharmaceuticals raised $65M on June 22, 2023

Investors: Ysios Capital, Gilde Healthcare, Lightstone Ventures, Oost NL and Meneldor

H

Hemispherian AS raised $3M on November 24, 2022

Investors: Kistefos AS and Meneldor

A

Atriva Therapeutics GmbH raised $10M on August 12, 2020

Investors: High-Tech Gründerfonds and Meneldor

A

Atriva Therapeutics GmbH raised undisclosed on January 3, 2019

Investors: High-Tech Gründerfonds and Meneldor

A

Aptamer Group raised $2.2M on June 29, 2018

Investors: Meneldor

FAQ